Amarin Corp Plc (AMRN)

[MedResCollab]

Flubber,

Our non-executive members did absolutely not want to be identified, which I (yes, I) expected. Imagine you are an academic at an institution and suddenly your employer gets dozens of phone calls complaining about something written that “implicates the institution,” with a variety of threats of lawsuits etc because they (the callers) are scared and overextended in an investment (probably options)?

Writing a factual but negative report on Amarin or any publicly traded company celebrated by a large group of retail holders (notice if we wrote a negative report on a private company few would care?) will bring this kind of backlash every time. I’ve been in the market for a while and am quite familiar with it.

Good luck to you.